Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
astrazeneca
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech
eli lilly
novartis
biosimilar
cancer
celgene
clinical trials
deals
duchenne muscular dystrophy
fda
fibrogen
What
bio
4
×
roundup
opioid
abbvie’s
acquisitions
alzheimer’s
august
barbecuing
biggest
biotech
build
busy
buy
camping
cardiologist
center
ceo
check
cholesterol
company’s
conference
congress
daniel
day
days
debut
decisions
democrats
devices
divided
drug
drugs
dyne’s
elections
fallout
fda
flop
gilead
hit
j
Language
unset
Current search:
astrazeneca
×
amgen
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel